OMGP (Oligodendrocyte-Myelin Glycoprotein) is a gene encoding a protein involved in neural development, myelination, and inhibition of neurite outgrowth.
---
| Attribute | Value |
|-----------|-------|
| Gene Symbol | OMGP |
| Full Name | Oligodendrocyte-Myelin Glycoprotein |
| Chromosome | 5p12 |
| NCBI Gene | 4974 |
| Ensembl | ENSG00000171570 |
| UniProt | P58304 |
| Aliases | OMG, p190 |
OMGP encodes oligodendrocyte-myelin glycoprotein (OMGp), a member of the reticulon family of proteins known for their roles in inhibiting axonal regeneration. The protein is expressed primarily by oligodendrocytes and plays critical roles in CNS development, myelination, and maintaining the inhibitory environment that prevents axonal regeneration after injury.
OMGp is a membrane-bound glycoprotein with several important functions:
- Myelin formation: Involved in the final stages of oligodendrocyte maturation and myelin compaction
- Neurite outgrowth inhibition: Acts as a potent inhibitor of neurite outgrowth through the Nogo receptor (NgR1) complex
- Axon-oligodendrocyte interactions: Mediates contact between axons and myelin sheaths
- Synaptic plasticity: Modulates synaptic structure and function in the mature CNS
OMGp exerts its inhibitory effects by binding to the Nogo receptor (NgR1) complex, which includes:
- Nogo-66 receptor (NgR1): The primary receptor for OMGp
- TROY/TAJ: Co-receptor that transduces the signal
- Lingo-1: Leucine-rich repeat and immunoglobulin-like domain-containing neurite outgrowth inhibitor protein 1
This receptor complex activates downstream signaling pathways including RhoA/ROCK, leading to growth cone collapse and inhibition of axonal regeneration.
OMGp shows specific expression patterns:
- White matter tracts: High expression in corpus callosum, internal capsule
- Oligodendrocytes: Particularly in mature, myelinating oligodendrocytes
- Cerebellum: Purkinje cell layer
- Spinal cord: Throughout white matter
- Cell membrane: Type I membrane protein
- Myelin sheaths: Localized to the outermost layer of myelin
- Synapses: Some expression at neuronal synapses
OMGP polymorphisms have been associated with MS susceptibility:
- Genetic association: Certain OMGP variants increase MS risk
- Demyelination role: OMGp may contribute to failed remyelination
- Therapeutic target: Blocking OMGp may enhance regeneration
- Motor neuron vulnerability: Altered OMGp expression in ALS
- Glial involvement: Oligodendrocyte dysfunction affects motor neurons
- Therapeutic potential: Modulating OMGp may protect motor neurons
- Myelin integrity: OMGp alterations affect white matter integrity
- Amyloid interactions: Possible interactions with amyloid pathology
- Cognitive decline: White matter abnormalities contribute to cognitive impairment
- Regeneration barrier: OMGp contributes to the inhibitory CNS environment
- Therapeutic blocking: Anti-OMGp antibodies promote axonal regeneration
- Combination therapy: OMGp blockade with other myelin inhibitors
- Location: Chromosome 5p12
- Exons: 6 exons spanning ~8 kb
- Transcript: Multiple splice variants
| Variant Type |
Effect |
Associated Conditions |
| Missense |
Altered function |
MS risk modifier |
| Promoter variants |
Altered expression |
ALS, MS |
| Copy number variants |
Gene dosage |
Neurodevelopmental |
Several therapeutic strategies target OMGp:
- Anti-OMGp antibodies: Neutralize OMGp's inhibitory activity
- NgR1 antagonists: Block the receptor to prevent signal transduction
- Decoy receptors: Soluble NgR1-Fc fusion proteins
- Small molecule inhibitors: ROCK inhibitors to block downstream signaling
- Spinal cord injury: Promotes axonal regeneration and functional recovery
- Multiple Sclerosis: May enhance remyelination
- Stroke: Potential for promoting neural repair
| Protein |
Receptor |
Function |
| Nogo-A |
NgR1 |
Myelin inhibition |
| MAG |
NgR1 |
Myelin inhibition |
| OMGp |
NgR1 |
Myelin inhibition |
| Lingo-1 |
NgR1/TROY |
Co-receptor |
¶ Interactions and Pathways
OMGp participates in several key pathways:
- Nogo-NgR1-Lingo-1 pathway: CNS regeneration inhibition
- RhoA/ROCK signaling: Growth cone collapse
- cAMP/PKA pathway: Counter-regulatory regeneration pathway
- MAPK/ERK pathway: Cell survival signaling
OMGp knockout mice show:
- Enhanced axonal regeneration after injury
- Improved functional recovery
- No major developmental abnormalities
- Subtle myelin ultrastructure changes
- Conditional knockout: Cell-type specific ablation
- Humanized models: Expressing human OMGp variants
The study of Omgp Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.